Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes
摘要:
Several pyrazolo-, triazolo-, and imidazolopyrimidines were synthesized and evaluated as inhibitors of DPP4. Of these three classes of compounds, the imidazolopyrimidines displayed the greatest potency and demonstrated excellent selectivity over the other dipeptidyl peptidases. SAR evaluation for these scaffolds was described as they may represent potential treatments for type 2 diabetes. (C) 2010 Elsevier Ltd. All rights reserved.
Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitors
摘要:
The synthesis and SAR of aminomethyl-substituted imidazolopyrimidine DPP4 inhibitors bearing varied pendant aryl groups is described. Compound 1, which exists as a separable mixture of non-interconvertible atropisomers was used as the starting point for investigation. The effects of substituent pattern and type as well as stereochemical effects on inhibitor potency are discussed. (C) 2010 Elsevier Ltd. All rights reserved.
AZOLOPYRIMIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHODS
申请人:Bristol-Myers Squibb Company
公开号:EP1836206A1
公开(公告)日:2007-09-26
US7635699B2
申请人:——
公开号:US7635699B2
公开(公告)日:2009-12-22
[EN] AZOLOPYRIMIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHODS<br/>[FR] INHIBITEURS AZOLOPYRIMIDINIQUES DE LA DIPEPTIDYL-PEPTIDASE IV, ET PROCEDES CORRESPONDANTS
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2006071752A1
公开(公告)日:2006-07-06
[EN] Compounds are provided having the formula (I): Formula (I) wherein R, X, Y, A and n are as defined herein. [FR] La présente invention concerne des composés représentés par la formule générale (I) dans laquelle R, X, Y, A et n sont tels que définis dans les spécifications.